score 英 /skɔː/ 美 /skɔ/
释义 n. 分数；二十；配乐；刻痕; vt. 获得；评价；划线，刻划；把…记下; vi. 得分；记分；刻痕
例句 Add up your score on each question.
作者： S.VAN DOORN
期刊：J. Thromb. Haemost.
Indications — Anticoagulant therapy is effective in reducing the risk of systemic embolization in patients with atrial fibrillation (AF). Anticoagulation with warfarin, dabigatran, rivaroxaban, apixaban, or edoxaban reduces this risk by almost 70 percent, and should be considered for most AF patients. However, the use of anticoagulant therapy is also associated with an increased risk of major bleeding. While the benefit outweighs the risk in most patients, careful consideration of the risk-to-benefit ratio is necessary in those at relatively very low (CHA2DS2-VASc score of 0) and low risk (CHA2DS2-VASc score of 1). Recommendations for anticoagulant therapy in patients with nonvalvular AF are as follows：For patients with a CHA2DS2-VASc score ≥2, we recommend chronic anticoagulation (Grade 1A)；For male patients with a CHA2DS2-VASc score of 1, our authors and reviewers have differing approaches, with some recommending no antithrombotic therapy and some recommending oral anticoagulant therapy. The risk factor present may influence decision making. Age 65 to 74 years is a stronger risk factor than the other features conferring a CHA2DS2-VASc score of 1；For patients with a CHA2DS2-VASc of 0 or 1 in females, we suggest no anticoagulant therapy (Grade 2C). Patients who are particularly stroke averse and who are at low bleeding risk may reasonably choose anticoagulation.